Enoxaparin Sodium Injection
Product Images NDC 28955-107

Product Visual Gallery

This gallery contains 30 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 28955-107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hebei Changshan Biochemical Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg (100mg)

Packaging label for enoxaparin sodium injection, USP, 100 mg/mL, in single-dose syringes with automatic safety device for subcutaneous injection. Label indicates a package of ten 1 mL syringes. The labeler is Hebei Changshan Biochemical Pharmaceutical Co., Ltd., with storage instructions and usage directions included on the carton.*

FDA Label Image

120mg (120mg)

Packaging label for Enoxaparin Sodium Injection, USP 120 mg/0.8 mL, single-dose syringes with automatic safety device for subcutaneous injection. The label includes dosage form, strength, syringe count (ten 0.8 mL syringes), manufacturer information (Hebei Changshan Biochemical Pharmaceutical Co., Ltd.), and safety instructions. The design features a purple color band highlighting the dosage strength and includes space for GTIN, lot, and expiration details.*

FDA Label Image

150mg (150mg)

Carton label for enoxaparin sodium injection, USP, 150 mg/mL, single-dose syringes with automatic safety device for subcutaneous injection. The label indicates 10 syringes of 1 mL each, with instructions for use and storage conditions. Manufactured in China by Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Includes barcode and NDC 28955-107-10.*

FDA Label Image

30mg (30mg)

Packaging label for Enoxaparin Sodium Injection, USP 30 mg/0.3 mL, a subcutaneous injection. The label includes dosing, administration, and safety instructions, noting it is for single-dose syringes with an automatic safety device. Manufactured by Hebei Changshan Biochemical Pharmaceutical Co., Ltd., with NDC 28955-101-10. The label indicates storage conditions and includes visual directions for use.*

FDA Label Image

40mg (40mg)

The image shows a flat carton packaging for Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL single-dose syringes. It includes text indicating automatic safety devices for subcutaneous injection and usage directions. The labeler is Hebei Changshan Biochemical Pharmaceutical Co., Ltd., and the packaging contains ten 0.4 mL syringes. NDC 28955-102-10, labeled Rx only.*

FDA Label Image

60mg (60mg)

Packaging label for Enoxaparin Sodium Injection, USP, 60 mg/0.6 mL, subcutaneous injection in single-dose syringes with automatic safety device. The label shows dosage information, directions for use, storage instructions, manufacturer (Hebei Changshan Biochemical Pharmaceutical Co., Ltd.), and a barcode. The box contains ten 0.6 mL syringes.*

FDA Label Image

80mg (80mg)

Packaging label for Enoxaparin Sodium Injection, USP 80 mg/0.8 mL by Hebei Changshan Biochemical Pharmaceutical Co., Ltd. The label specifies single dose syringes with automatic safety devices for subcutaneous injection. Instructions for use and storage conditions are included, along with dosage details. The package contains ten 0.8 mL syringes. NDC 28955-104-10 is displayed.*

FDA Label Image

Enoxafigurea (Enoxa Figure A)

An instructional illustration showing a person holding a syringe with both hands, demonstrating the action of pulling the syringe parts apart or pushing them together, indicated by a double-headed arrow pointing horizontally between the hands.*

FDA Label Image

Enoxafigureb (Enoxa Figure B)

Instructional illustration showing the administration of enoxaparin sodium injection subcutaneously. The image depicts a hand holding a prefilled syringe inserted at an angle under the skin of the forearm, indicating the subcutaneous route of administration.*

FDA Label Image

Enoxafigurec (Enoxa Figure C)

An instructional illustration showing the administration of a subcutaneous injection. A hand is shown holding a syringe angled towards the skin of a patient's arm, preparing to inject the medication. The image conveys proper injection technique for subcutaneous use.*

FDA Label Image

Enoxafigured (Enoxa Figure D)

An instructional illustration showing a hand holding an injection syringe with a needle cap being removed, indicated by a blue arrow. The image relates to subcutaneous injection preparation for enoxaparin sodium injection.*

FDA Label Image

Enoxafiguree (Enoxa Figure E)

An instructional illustration showing a gloved hand disposing of a needle or syringe into a container labeled with a biohazard symbol, indicating proper disposal of injection-related waste.*

FDA Label Image

Enoxastructuralformula (Enoxa Structural Formula)

Chemical structure of enoxaparin sodium showing repeating disaccharide units with variable sulfate groups (R1 and R2), and a tabular summary of structural variations including values for R and n representing degree of polymerization.*

FDA Label Image

Enoxafigure1 (Enoxafigure1)

A relative risk forest plot comparing the effectiveness of enoxaparin sodium injection versus unfractionated heparin (UFH) across various patient subgroups. The chart displays subgroup categories, number of patients, relative risk points, and percentage reductions in risk for each group, indicating comparative outcomes between enoxaparin and UFH treatments.*

FDA Label Image

Enoxafigure2 (Enoxafigure2)

A Kaplan-Meier hazard distribution curve comparing enoxaparin and unfractionated heparin (UFH) over time to death or myocardial re-infarction in days. The graph shows hazard rates for both treatments with a log-rank test p-value of less than 0.0001. A smaller inset graph displays hazard distribution up to one year, also showing statistical significance.*

FDA Label Image

Enoxinstuse1 (Enoxinstuse1)

An instructional illustration comparing an injection syringe before and after use. The 'Before Use' syringe shows a plunger rod, needle with needle cap removed, and the drug inside. The 'After Use' syringe shows the plunger rod pushed in and a protective sleeve covering the needle. Labels identify the parts in both states.*

FDA Label Image

Enoxinstuse10 (Enoxinstuse10)

An instructional illustration showing a hand pinching the skin on the abdomen, likely demonstrating the technique for subcutaneous injection administration.*

FDA Label Image

Enoxinstuse11 (Enoxinstuse11)

An instructional illustration depicts a hand holding a syringe at a 90-degree angle to the body, demonstrating the proper technique for subcutaneous injection of enoxaparin sodium. The diagram emphasizes the angle and positioning for administering the injection.*

FDA Label Image

Enoxinstuse12 (Enoxinstuse12)

An instructional illustration showing the administration of a subcutaneous injection in the abdominal area. The image depicts one hand pinching the skin while the other hand inserts a syringe at an angle into the skin, with an arrow indicating the direction of injection.*

FDA Label Image

Enoxinstuse13 (Enoxinstuse13)

An instructional diagram illustrating the method of subcutaneous injection. The image shows a person pinching the skin on the abdomen with one hand while holding a syringe with the other hand, preparing to inject at a 90-degree angle to the skin.*

FDA Label Image

Enoxinstuse14 (Enoxinstuse14)

An instructional illustration showing how to use a prefilled syringe by pressing a button to activate the protective sleeve. A hand holds the syringe, indicating the injection device design for enoxaparin sodium subcutaneous injection.*

FDA Label Image

Enoxinstuse15 (Enoxinstuse15)

An instructional diagram showing a hand holding an enoxaparin sodium injection syringe. The syringe's needle cap is being safely disposed of into a labeled sharps disposal container.*

FDA Label Image

Enoxinstuse2 (Enoxinstuse2)

Illustration showing components for subcutaneous injection of enoxaparin sodium, including a prefilled syringe labeled for enoxaparin sodium, a sharps disposal container, one cotton ball or gauze, one alcohol wipe, and one small adhesive bandage. The diagram is labeled as Figure A.*

FDA Label Image

Enoxinstuse3 (Enoxinstuse3)

An instructional diagram showing a person peeling the backing off an adhesive bandage or patch, with one hand holding the bandage and the other hand pulling away the protective strip. The illustration is in grayscale and depicts the preparation or application step for a device or medical adhesive.*

FDA Label Image

Enoxinstuse4 (Enoxinstuse4)

Illustration of a prefilled syringe for enoxaparin sodium injection, showing the syringe barrel, plunger, needle cap, and a label area indicating the expiration date. Intended for subcutaneous administration.*

FDA Label Image

Enoxinstuse5 (Enoxinstuse5)

A black and white line drawing illustration of a syringe filled with a clear liquid. The syringe shows a plunger, barrel, and needle cover, with the label indicating the liquid inside is clear. This diagram likely represents the injection form of enoxaparin sodium for subcutaneous use.*

FDA Label Image

Enoxinstuse6 (Enoxinstuse6)

An instructional diagram showing the lower abdominal area from the front, with two gray shaded squares on the left and right sides, indicating sites for subcutaneous injection administration.*

FDA Label Image

Enoxinstuse7 (Enoxinstuse7)

An instructional illustration showing a hand holding a small adhesive patch near a person's lower abdomen, likely demonstrating the application of a subcutaneous injection site for enoxaparin sodium injection.*

FDA Label Image

Enoxinstuse8 (Enoxinstuse8)

An instructional diagram showing two hands preparing an injection. One hand holds a syringe with the needle exposed, while the other hand holds a protective needle cap being pulled away from the syringe, indicating removal before use.*

FDA Label Image

Enoxinstuse9 (Enoxinstuse9)

An instructional illustration showing a hand adjusting the plunger of a syringe to set the dose for an injection. Black dosage markings are visible on the syringe barrel, with an arrow pointing downward and text labeled "Set your dose" to guide proper dose setting.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.